Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|December 8, 2019
Molecular hydrogen suppresses superoxide generation in the mitochondrial complex I and reduced mitochondrial membrane potentialGenki Ishihara, Kosuke Kawamoto, Nobuaki Komori, et al.
Clinical Drug Investigation|September 12, 2018
Evaluation of Drug-Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy SubjectsNao Kawaguchi, Hiroki Koshimichi, Toru Ishibashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 10, 2014
Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairmentYumiko Matsuo, Toru Ishibashi, Ryuji Kubota, et al.
Biochemistry|April 27, 2005
Multiple enzyme activities of Escherichia coli MutT protein for sanitization of DNA and RNA precursor poolsRiyoko Ito, Hiroshi Hayakawa, Mutsuo Sekiguchi, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Population pharmacokinetics of peramivir in healthy volunteers and influenza patientsYumiko Matsuo, Toru Ishibashi, Alan S Hollister, et al.
Drug Metabolism and Pharmacokinetics|January 18, 2006
Evaluation of Bayesian predictability of vancomycin concentration using population pharmacokinetic parameters in pediatric patientsAyako Ohnishi, Yoshitaka Yano, Toru Ishibashi, et al.
Journal of Pharmaceutical Sciences|April 12, 2019
Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen AssessmentYumiko Matsuo, Toru Ishibashi, Sayaka Matsumoto, et al.
Antiviral Therapy|November 3, 2016
Pharmacokinetics and safety of intravenous peramivir, neuraminidase inhibitor of influenza virus, in healthy Japanese subjectsYutaka Saisho, Toru Ishibashi, Hidenori Fukuyama, et al.
Pageof 6